Ptc Therapeutics Inc (PTCT)

R&D Expense Growth

-1.71%

Quarterly · Period ending:

PTCT logo

PTCT R&D Expense Growth

Latest reported-1.71%
PTCT Quarterly R&D Growth (QoQ) (0.00% → -1.71%)
High-resolution chart · PNG

PTCT r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Ptc Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-1.7081%
-24.2286%
32.918%
-11.3568%
3.6862%
-12.6609%
-22.7009%
22.1255%
13.8122%
-4.3048%
-26.0998%
-11.6541%
-4.7406%
3.4076%
14.0407%
5.2136%
12.2682%
-6.5174%
14.5202%
4.2739%
-6.7138%
13.9815%
26.8984%
-47.3174%
95.906%
10.1135%
29.734%
5.1635%
14.1023%
-2.015%
-1.3261%
66.7372%
3.9665%
7.2826%
-2.6312%
-2.6301%
12.6887%
5.1978%
-17.1519%
8.9118%
-8.1913%
-10.4114%
14.3864%
8.691%
0.902%
3.9708%
43.1974%
2.4682%
15.2558%
5.7854%
8.1652%
-5.6137%
30.6948%
19.1188%
-9.7108%
-12.1868%
-16.6698%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.